{
    "2020-12-01": [
        [
            {
                "time": "2021-03-01",
                "original_text": "Activist Shareholders Press Pfizer, J&J, and Other Pharma Companies on Covid Vaccine Price and Access",
                "features": {
                    "keywords": [
                        "activist",
                        "shareholders",
                        "Pfizer",
                        "J&J",
                        "Covid",
                        "vaccine",
                        "price",
                        "access"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-02",
                "original_text": "Want to Invest in Coronavirus Vaccines? Consider This First",
                "features": {
                    "keywords": [
                        "invest",
                        "coronavirus",
                        "vaccines"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-03",
                "original_text": "New Advances in Treating Difficult Blood Cancers From Johnson & Johnson and Others",
                "features": {
                    "keywords": [
                        "advances",
                        "blood cancers",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "I’ve already been injected with a COVID vaccine. This is why I’m cheering for the Novavax underdog",
                "features": {
                    "keywords": [
                        "COVID",
                        "vaccine",
                        "Novavax",
                        "underdog"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "Cramer Weighs In On Peloton, Johnson & Johnson And More",
                "features": {
                    "keywords": [
                        "Cramer",
                        "Peloton",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-03-06",
                "original_text": "Moderna (MRNA) Seeks Nod for Emergency Use of COVID-19 Vaccine",
                "features": {
                    "keywords": [
                        "Moderna",
                        "emergency use",
                        "COVID-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-07",
                "original_text": "AstraZeneca (AZN) Forxiga Approved in Japan for Heart Failure",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Forxiga",
                        "Japan",
                        "heart failure"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "cardiology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-08",
                "original_text": "New Survey Finds Critical Need for Education on Cataracts and Modern Treatment Options",
                "features": {
                    "keywords": [
                        "survey",
                        "cataracts",
                        "treatment options"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "ophthalmology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-09",
                "original_text": "Here's Why Johnson & Johnson Is Still in the Coronavirus Vaccine Race",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Coronavirus",
                        "vaccine race"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}